We continue to discuss a recent study that examines the role of Myeloid-derived Suppressor Cells in cancer and the expression of a receptor, DR-5, as a way to target these cells.
Article: Condamine T, Kumar V, Ramachandran IR, et al. ER stress regulates myeloid-derived suppressor cell fate through TRAIL-R-mediated apoptosis. J Clin Invest. 2014;124(6):2626-2639. doi:10.1172/JCI74056 <a href="https://pubmed.ncbi.nlm.nih.gov/24789911/" rel="ugc noopener noreferrer" target="_blank">⁠https://pubmed.ncbi.nlm.nih.gov/24789911/</a>

We continue to discuss a recent study that examines the role of Myeloid-derived Suppressor Cells in cancer and the expression of a receptor, DR-5, as a way to target these cells. Article: Condamine T, Kumar V, Ramachandran IR, et al. ER stress regulates myeloid-derived suppressor cell fate through TRAIL-R-mediated apoptosis. J Clin Invest. 2014;124(6):2626-2639. doi:10.1172/JCI74056 ⁠https://pubmed.ncbi.nlm.nih.gov/24789911/

We continue to discuss a recent study that examines the role of Myeloid-derived Suppressor Cells in cancer and the expression of a receptor, DR-5, as a way to target these cells.
Article: Condamine T, Kumar V, Ramachandran IR, et al. ER stress regulates myeloid-derived suppressor cell fate through TRAIL-R-mediated apoptosis.&nbsp;J Clin Invest. 2014;124(6):2626-2639. doi:10.1172/JCI74056 <a href="https://pubmed.ncbi.nlm.nih.gov/24789911/" rel="noopener noreferrer">⁠https://pubmed.ncbi.nlm.nih.gov/24789911/</a>

MDSCs in Cancer (Part II)

"Immunology Digest", hosted by Amir Rahmati, breaks down and simplifies the latest research and discoveries in immunology. Whether you're a student, a scientist, or simply curious about the immune system, this podcast offers in-depth insights into the cellular and molecular processes driving immune responses and the latest advancements shaping the field.

Share MDSCs in Cancer (Part II)

Sign up to save your podcasts

MDSCs in Cancer (Part II)

MDSCs in Cancer (Part II)